A browser-based multi-omics research factory (MORF) adapted for plant genomes, enabling integration of metabolomics and transcriptomics data to link genes to phenotype. Applied to Amaranthus, a drought-tolerant African leafy vegetable, to accelerate breeding of improved varieties with enhanced nutritional traits.
This project adapts the MORF multi-omics research factory, a browser-based data integration platform, for use with complex plant genomes. Originally developed to create digital twins of microbial systems, MORF will be extended to handle large eukaryotic genomes for the first time, using Amaranthus as the inaugural plant model. The platform integrates genome, transcriptome, metabolome, and phenome data into a single explorable resource, enabling researchers to map metabolites to metabolic pathways and connect gene function to plant phenotypes. By applying MORF to Amaranthus, a drought-tolerant and nutritious leafy vegetable important for food security in Sub-Saharan Africa, the project aims to accelerate breeding of improved varieties with enhanced agronomic and nutritional traits.
Core platform capabilities:
Amaranthus project specifics:
The MORF platform has over five years of development history and has been successfully validated in bacterial systems for stress response analysis and systems metabolic engineering. It has been implemented in a simple eukaryotic system but never for a large complex eukaryote prior to this project. The Amaranthus dataset is already collected and ready for import. The proposed project is scoped at six to twelve months, using MORF staff and seconded personnel from the collaborating research group. Upon completion, the adapted platform will provide a data architecture applicable to other plant genomes, enabling broader multi-omics research across crop species.
The University of York is a comprehensive public research university and member of the UK’s Russell Group in the city of York, England. Adjacent to campus, a research and technology park hosts SMEs, startups and corporate R&D alongside university groups, providing low-friction access to facilities and talent. Industry engagement is further enabled by a joint medical school with the University of Hull and placements across regional NHS trusts, supporting clinical studies and translational partnerships. Research is supported by competitive funding from UK Research and Innovation, the National Institute for Health and Care Research, and major charities such as Wellcome. A dedicated technology transfer and enterprise function provides IP management, licensing and spinout support, offering clear routes for collaboration.